For the first time, a CRISPR drug treats a child’s unique mutation
Pioneering CRISPR Therapy Successfully Targets Rare Genetic Defect in Young Patient
Researchers are anticipating that this breakthrough could pave the way for wider therapeutic applications for other pediatric patients.
Source: The Economist Generated at: 2025-05-15 17:00:00 UTC






